Human immune responses to the UK human anthrax vaccine

被引:21
作者
Baillie, LWJ
Fowler, K
Turnbull, PCB
机构
[1] DERA, Chem & Biol Def Sector, Salisbury SP4 0JG, Wilts, England
[2] Ctr Appl Microbiol & Res, Salisbury SP4 0JG, Wilts, England
关键词
D O I
10.1046/j.1365-2672.1999.00899.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The IgG anti-protective antigen subclass antibody response of individuals who had been infected with anthrax was compared with that of healthy individuals immunized with the UK licensed anthrax vaccine. The predominant subclass in both groups was IgG1. In addition, IgG3 was seen in convalescent serum while vaccinees produced IgG2, IgG3 and IgG-C subclass. The significance of these results is discussed. Further work is required to determine the role of antibodies in mediating protective immunity in man.
引用
收藏
页码:306 / 308
页数:3
相关论文
共 10 条
[1]  
Baillie L. W. J., 1996, SALISBURY MED B S, V87, P133
[2]  
DARLOW HM, 1956, LANCET, V11, P476
[3]   Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen [J].
Gu, ML ;
Leppla, SH ;
Klinman, DM .
VACCINE, 1999, 17 (04) :340-344
[4]  
Lindmark B, 1995, CLIN REHABIL, V9, P1, DOI DOI 10.1177/026921559500900101
[5]   Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs [J].
Little, SF ;
Ivins, BE ;
Fellows, PF ;
Friedlander, AM .
INFECTION AND IMMUNITY, 1997, 65 (12) :5171-5175
[6]   Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers [J].
McBride, B ;
Mogg, A ;
Telfer, JL ;
Lever, MS ;
Miller, J ;
Turnbull, PCB ;
Baillie, L .
VACCINE, 1998, 16 (08) :810-817
[7]  
PARISH WE, 1975, ALLERGY, P153
[8]   The IgG isotypes of specific antibodies in patients with American cutaneous leishmaniasis; Relationship to the cell-mediated immune response [J].
Rodriguez, V ;
Centeno, M ;
Ulrich, M .
PARASITE IMMUNOLOGY, 1996, 18 (07) :341-345
[9]  
Sousa AO, 1998, CLIN EXP IMMUNOL, V111, P48
[10]  
1996, IMMUNOLOGY, pCH4